A PYMNTS Company

US: Baxter puts price-fixing woes behind with $64M settlement

By  |  April 21, 2014

Baxter International has finally put a price-fixing lawsuit against the health care giant behind as a federal judge finalized the company’s $64 million settlement.

Reports say the company’s offer puts the total amount of damages recovered by the plaintiffs in the case to $128 million.

The class action sued accused Baxter and other companies of colluding to fix the price of a blood plasma derivative, collaborating to restrict its supply to hike prices between 2003 and 2009.

Among the companies that have settled include CSL Limited, CSL Behring, CSL Plasma, and the Plasma Protein Therapeutics Association. Those firms similarly settled for $64 million, an offer that was finalized earlier this yea by US District Judge Joan B. Gottschall.

Full Content: Market Watch

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.